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ABSTRACT A common DNA binding and dimerization
domain containing an apparent "helix-loop-helix" (HLH)
structure was recognized recently in a number of regulatory
proteins, including the E47 and E12 proteins that bind to the
KE2 motif in immunoglobulin X gene enhancer. The effect of
site-directed mutagenesis on E47 protein multimerization and
DNA binding was examined. Mutations in either putative helix
domain disrupted protein dimerization and DNA binding. No
DNA binding was observed when mutations were introduced in
the basic region, but these mutants were able to dimerize.
These basic region mutants were not able to bind to DNA as
heterodimers with the wild-type E47 proteins, demonstrating
that two functional basic regions are required for binding to
DNA. Therefore the basic region mutants are "trans-
dominant."
The protein products of the E2A gene, E47 and E12, form
homo- and heterodimers that recognize the KE2 site of the
immunoglobulin K gene enhancer (1, 2). The KE2 site plays a
critical role in the function of the enhancer (3, 4). A DNA site
similar to the KE2 sequence is also found in the insulin gene
enhancer (5) and in the muscle creatine kinase gene enhancer
(6), and both are important for the tissue-specific expression
of their respective genes. The protein products of the three
genes that induce myogenesis, MyoD (7, 8), myogenin (9),
and myf-5 (10) all share with E47 a highly conserved 60-amino
acid stretch with predicted helix-loop-helix (HLH) structure
(2) and act presumably by way of interaction with the
KE2-like sequences in the muscle-specific genes. Other mem-
bers ofthe "HLH family" have been defined based on amino
acid sequence homology to the region of the E47 polypeptide
required for specific recognition ofDNA and include the myc
family proteins; proteins important for Drosophila develop-
ment, including the achaete-scute complex (11, 12), daugh-
terless (13), twist (14), and Enhancer of split (15); and the lyl-l
gene implicated in T-cell acute lymphoblastic leukemia (16).
These proteins all contain a basic amino acid region followed
by two short putative amphipathic helices separated by an
intervening region that might form a loop, the HLH motif. In
addition to homodimers, the HLH proteins can also form
heterodimers that bind specifically to a common DNA se-
quence (2). Deletion mutagenesis analysis of the E47/E12
proteins showed that the basic region and HLH domain,
which are located at the carboxyl terminus, are sufficient for
the DNA binding activity in vitro (1, 2). To define further the
regions required for specific contact with DNA and for dimer
formation, as well as to determine whether the two can be
functionally separated, site-directed mutagenesis of the E47
gene was performed. Experimental evidence is presented
here that the amphipathic helices mediate complex formation
between E47 proteins that results in the appropriate juxta-
position of the DNA binding region of the protein. Further-
more, dimerization is required for DNA binding, which also
depends on a specific sequence of basic amino acids, posi-
tioned immediately amino-terminal to the HLH motif. In the
absence of the DNA binding, however, dimerization still
occurs.
MATERIALS AND METHODS
Plasmids. Construction of the pE47P and pE47S plasmids
encoding two truncated versions of the E47 protein, E47P
and E47S, has been described (1).
Site-Directed Mutagenesis of E47. Mutations were con-
structed by gapped heteroduplex oligonucleotide replace-
ment using pE47S plasmid DNA. The structure of each
mutant was confirmed by dideoxynucleotide sequencing of
the double-stranded DNA using Sequenase (United States
Biochemical).
In Vitro Transcription and Translation. Plasmid DNA was
linearized with EcoRI and used as a template for in vitro
transcription with T3 RNA polymerase (Stratagene). Wild-
type and mutant proteins were synthesized using rabbit
reticulocyte lysates (Promega) in the presence of [35S]me-
thionine (Amersham).
DNA Binding Assay. The EcoRI-HindIII fragment contain-
ing the wild-type KE2 sequence was labeled with 32p (50,000
cpm/ng), and 0.5 ng ofDNA probe was incubated with 5-10
,ul of the reacted or unreacted reticulocyte lysate (detailed in
the figure legends). The binding reactions were incubated at
room temperature for 15 min and complexes were resolved
by electrophoresis as described (1).
Immunoprecipitation. Proteins synthesized in vitro in the
presence of [35S]methionine (Amersham) were dissolved in
ELB buffer (250 mM NaCI/0.1% Nonidet P-40/50 mM
Hepes, pH 7.0/5 mM EDTA/1.0 mM phenylmethylsulfonyl
fluoride/0.5 mM dithiothreitol) and incubated on ice for 1 hr
in the presence of 1 ,ul of a rabbit polyclonal antibody raised
against the carboxyl-terminal 440 amino acids of E12 (2). The
immune complexes were isolated by incubation with 25 ,ul of
protein A Sepharose (Sigma), washed four times at 4°C with
ELB buffer, and resolved by electrophoresis on NaDodSO4/
20% polyacrylamide gels.
RESULTS
Mutagenesis ofE47S. The E47 and E12 polypeptides are the
protein products resulting from the alternative splicing of the
E2A gene and differ only in their carboxyl-terminal exon,
which encodes basic and HLH regions (X. H. Sun and D.B.,
unpublished). Deletion mutagenesis defined a region of the
E47 polypeptide containing amino acids 313-495 as a domain
sufficient for the specific recognition of the KE2 DNA motif
Abbreviations: HLH, helix-loop-helix; EMSA, electrophoretic mo-
bility shift assay.
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FIG. 1. Immunoprecipitation analysis of the protein complexes
with E12-specific antibody. The in vitro-translated products were
incubated in the absence of DNA as described in the text, and the
immunoprecipitates formed with an E12 antibody were analyzed on
a NaDodSO4/20%o polyacrylamide gel. Mutant sequences are shown
in Fig. 2. Positions of E47P and E47S are marked by arrows. The
background bands are the products of the E47P in vitro translation
and are caused either by the premature terminations or protein
degradation.
(1). This truncated version of the protein, E47S, can form
homodimers as well as heterodimers with other members of
the HLH family and can bind specifically to its cognate DNA
motif (1, 2). Because the truncated E47S protein does not
contain the amino-terminal region shared between E12 and
E47 proteins (1), we predicted and confirmed that the E12-
specific serum would recognize E47P protein but not its
truncated form, E47S (Fig. 1, lanes 1 and 2). However, when
the E47S and E47P proteins were combined in the absence of
DNA and then subjected to immunoprecipitation, the trun-
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cated E47S protein was readily detected in a complex with
the E47P protein (Fig. 1, lane 3). This result demonstrates
that E47 polypeptides are able to multimerize in the absence
of DNA. To define precisely the regions involved in protein
complex formation and DNA binding, we introduced site-
specific mutations into the E47S polypeptide in the regions of
sequence conservation among the members of the HLH
family (Fig. 2). Wild-type and mutant proteins were synthe-
sized in vitro, and coimmunoprecipitation was used to de-
termine the effect of site-directed mutagenesis on protein
complex formation. The ability of the E47S mutant proteins
to bind DNA was analyzed by an electrophoretic mobility
shift assay (EMSA) with 32P-labeled DNA probe containing
the KE2 sequence GGCAGGTGG.
Amphipathic Helices Mediate Dimerization. The positions
of the conserved hydrophobic amino acid residues in the
amphipathic helices form a four-three repeat, which would
bring them to one side of a helix. By analogy with the
intermediate filaments, it was proposed that these amino
acids allow hydrophobic interaction between the helices
during protein dimerization via a coiled-coil structure (1). To
test this hypothesis, single and double mutations were intro-
duced at these conserved residues. Mutant protein was
synthesized in vitro, mixed with the wild-type E47P protein,
preincubated in the absence of DNA, and subjected to
immunoprecipitation with the E12-specific serum. The one
singly mutant protein, E47S.11, was coimmunoprecipitated
with E47P (Fig. 1, lane 13). However, all of the double
mutants, E47S.12, E47S.16, E47S.17, and E47S.19, were not
detected in the immunoprecipitates (Fig. 1), implying that the
mutations disrupted dimerization. We next tested the ability
of the mutants to bind DNA. When a mixture of wild-type
E47S and E47P proteins was used for the DNA binding assay,
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FIG. 2. Site-directed mutants of E47S: Amino acid sequence of the carboxyl-terminal region of E47 protein (amino acids 336-393)
encompassing the HLH domain (1). The results of DNA binding assay and immunoprecipitation for dimer formation between the E47P and
mutants are shown on the left. Solid lines mark the amphipathic helices and basic domain. Asterisks indicate amino acids identity among the
members of the HLH family.
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FIG. 3. DNA binding activity of HLH region mutants. The in vitro-translated proteins were analyzed by EMSA using a KE2 monomer as
a probe. Mutant sequences are shown in Fig. 2. (Left) DNA binding by mutants of the helices. (Right) DNA binding by loop mutants. C1, C2,
and C3 indicate E47P-, E47S-, and E47P/E47S heterodimer-specific complexes. F designates the position of the free DNA probe. Minus sign
(-) corresponds to "no RNA" in vitro translation reaction mixture.
three complexes, C1, C2, and C3, corresponding to the E47P
and E47S homodimers and the E47S/E47P heterodimer,
respectively, were formed (Fig. 3 Left, lane 8). A double
mutation in the amphipathic helix I that replaced phenyl-
alanine and leucine by aspartic and glutamic acids resulted in
the absence of a complex with the KE2-specific DNA probe
(Fig. 3 Left, lane 1). No heterodimer complex was detected
when this mutant E47S protein was combined with the
wild-type E47P protein (Fig. 3 Left, lane 2). A series ofdouble
mutations in the amphipathic helix II, E47S.16, E47S.17, and
E47S.19, also abolished DNA binding as homo- and het-
erodimer, whereas the single mutation, E47S.11, resulted in
a weaker binding to the specific DNA probe (Fig. 3 Left, lanes
3 and 4). Substitution of alanine for the highly conserved
lysine positioned amino-terminal in the amphipathic helix II
completely disrupted dimerization (Fig. 1, lane 7) and abol-
ished DNA binding (Fig. 1, lanes 15 and 16). Because this
charged residue is strongly conserved among the HLH pro-
teins, it is apparently providing stability to the dimer. There-
fore we concluded that dimerization is required for DNA
binding, since the mutations in the helix I and helix II that
disrupted dimerization of the proteins resulted in the inability
to bind to DNA.
Loop Region Separates the Two Helices. We next introduced
mutations within the loop region to assess its contribution to
dimerization and subsequent DNA binding. A few random
mutations within the region produced no significant changes
in protein dimerization and binding to DNA. A double
mutation that replaced methionine and histidine by isoleucine
and aspartic acid resulted in essentially wild-type dimeriza-
tion (Fig. 1, lane 8) and binding to DNA (Fig. 3 Right, lanes
1 and 2). Similarly, mutation of a lysine to isoleucine pro-
duced no effect on dimerization and the subsequent DNA
binding (Figs. 1 and 3 Right). Insertion of the four amino acid
residues in the middle of the loop (mutant E47S.23) resulted
in weaker dimerization that is indicated by a less stable
complex with the wild-type E47P during immunoprecipita-
tion (Fig. 1, lane 9). The destabilization of the protein dimer
in turn reduced the ability of the mutant to bind DNA as a
heterodimer (Fig. 3 Right, lane 5). However, the mutant
protein formed a strong complex with DNA as a heterodimer
(Fig. 3 Right, lane 6). It appears, therefore, that the loop
region sequence does not play a critical role in E47 protein
dimerization and binding to DNA, but it may have a function
of providing a structural element separating the two helices.
Effect of the Basic Region on Binding to DNA. A charged
region positioned immediately amino-terminal to the HLH
domain is structurally conserved among the members of the
HLH family (1). A few clusters of basic amino acids-in
particular, arginines-are present at the fixed positions
within this region, perhaps implicating this domain in DNA
binding. We therefore analyzed the effect of the alteration of
these residues on E47 protein dimerization and binding to
DNA. Double mutations of the highly conserved arginine
residues to glycines, E47S.09 and E47S.10, completely abol-
ished DNA binding (Fig. 4, lanes 4 and 6). Surprisingly, DNA
binding was absent in all of the mutants with a single
substitution of arginine to lysine at each of the three highly
conserved positions (Fig. 4, lanes 8, 10, and 12), suggesting
an important role of these residues in binding to DNA. All of
awe.
FIG. 4. DNA binding activity of the basic region mutants. The in
vitro-translated products were analyzed by EMSA using a KE2
monomer as a probe. Mutant sequences are shown in Fig. 2. C1, C2,
and C3 indicate E47P-, E47S-, and E47P/E47S heterodimer-specific
complexes. F designates the position of the free DNA probe.
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FIG. 5. DNA binding activity of E47P in the presence of E47S
mutants. Two microliters of in vitro synthesized E47P was mixed
with the indicated amount of mutant protein; "no RNA" in vitro
translation reaction mixture was added to the final volume of 10 ,ul.
Protein binding activity was analyzed by EMSA using a KE2 mono-
mer as a probe. Arrow indicates the position of E47P-specific
complex. Minus sign (-) corresponds to "no RNA" in vitro trans-
lation reaction mixture alone.
these mutations also prevented DNA binding as heterodimers
with the wild-type E47P protein (Fig. 4, lanes 9, 11, and 13).
However, when the basic region mutant proteins were com-
bined with the wild-type E47P protein and subjected to
immunoprecipitation with E12-specific serum, they were
readily detected in the precipitates (Fig. 1, lanes 11, 12, and
15-17). Mutations of the basic region therefore did not
interfere with the ability of the protein to dimerize, but they
did abolish binding to DNA. We propose therefore that the
basic region of the protein-in particular, the highly con-
served arginine residues present at the fixed positions within
the region-are necessary for specific contact with DNA.
The DNA binding surface of the protein is apparently formed
by dimerization of the polypeptides.
Trans-Dominant Suppression of Binding to DNA. The E47S
basic region mutant proteins were able to form dimers with
the E47P wild-type protein but completely lacked the ability
to bind DNA. These mutations also abolished binding to
DNA as heterodimers with the wild-type E47P protein. We
therefore assayed the DNA binding activity associated with
E47P when increasing amounts of the basic region mutant
proteins (mutant E47S.15 is shown here as an example) were
added to the reaction mixture (Fig. 5, lanes 3-5). Disappear-
ance of the E47P-specific homodimer complex indicates that
these mutants interfere with DNA binding in a dominant
fashion. This phenomenon was not observed with the HLH
domain mutants (Fig. 5, lanes 6-8), which were shown to be
defective in dimerization. Suppression of the binding to DNA
occurs when a mutant in the basic (DNA binding) region
forms a heterodimer complex with a wild-type protein. This
finding provided strong evidence that both polypeptides in a
dimer contribute directly to a functional DNA binding do-
main and that two intact basic regions are required for
interaction with DNA.
DISCUSSION
Experiments presented here establish that the HLH region
common to a family of genes is responsible for the dimer-
ization of the immunoglobulin K gene enhancer binding
protein, E47. Substituting charged amino acids for pairs of
relevant hydrophobic amino acid residues in the proposed
amphipathic helices is sufficient to disrupt dimer formation.
Complex formation, however, remains unperturbed by mu-
tation of a single hydrophobic residue. This observation is
similar to the effect of the single and double mutations of the
"leucine zipper" of the Fos-Jun heterodimer (17, 18). In
addition to the hydrophobic amino acids, the lysine con-
served among the HLH family that is positioned at the amino
terminus of helix II is required for dimerization. Substituting
alanine for this lysine abolished dimerization and subsequent
DNA binding, implying that this charged residue contributes
to the interaction between the two polypeptides. All of the
mutations that interfered with protein dimerization also abol-
ished binding to DNA. Therefore, interaction of the amphi-
pathic helixes may have a fundamental role in assembling a
functional DNA binding surface of protein. The substitutions
of residues in the loop region, although targeted randomly,
did not produce any significant changes in protein dimeriza-
tion and DNA binding. Because the region is variable in the
amino acid sequence and length among the HLH family, it is
unlikely that the loop directly contributes to the dimerization
between the HLH proteins. It probably serves as a structural
element that separates the two helices and facilitates their
spatial juxtaposition during dimerization. Direct structural
experiments will be required for a detailed understanding of
the complex formation between E47 polypeptides.
Mutagenesis of the basic region found immediately amino-
terminal of helix I shows that its highly conserved arginine
residues are required forDNA binding by the E47 dimer. This
DNA-protein recognition is not due simply to ionic interac-
tion between the charges of the phosphate backbone of the
DNA and basic amino acid residues, because even a single
conservative substitution of another basic amino acid, lysine,
for the relevant arginines still disrupted DNA binding. These
results define a specific DNA binding motif for the HLH
family of proteins. Similarly, a study of mutants of a muscle
differentiation factor, MyoD, defined the HLH domain to-
gether with the basic region as necessary and sufficient for
DNA binding and myogenesis (19).
A model for a well-studied family ofDNA binding proteins
that contain the leucine zipper structure was proposed re-
cently (20). This model is based on the recognition ofthe dyad
symmetric DNA binding site by two DNA contact surfaces
brought together due to a specific interaction of a dimeriza-
tion interface of the leucine zipper. Since the DNA target
sequence recognized by the E47 protein present in the
immunoglobulin gene enhancer has a dyad symmetry struc-
ture (3), it is likely that dimerization of the E47 polypeptides
juxtaposes their basic domains with the KE2 DNA motif. This
model is in good agreement with the finding that although the
E47 basic region mutants were able to form dimers with the
wild-type E47 protein, the dimers were deficient in binding to
DNA. These basic region mutants of E47 are "trans-
dominant" in that they interfere with DNA binding by the
wild-type E47P protein. In vivo, it is possible that E47 usually
binds to DNA as a heterodimer with another HLH protein.
A negative regulation or modulation of the enhancer could be
achieved by dimerization of E47 with a HLH protein lacking
a DNA binding domain, similar to the newly reported Id
protein (22). The E47 basic region mutants could mimic this
effect and therefore could be used for in vivo analysis of the
biological function of the HLH proteins.
The amino-terminal portion of the E47 and E12 proteins
contain a leucine zipper structural motif (1) and a transcrip-
tion-activating sequence (21). Deletion studies demonstrated
that this region of the polypeptides clearly is not required for
binding to the KE2 site in vitro (1). However it is quite
possible that either tissue-specific or ubiquitous factors in-
teract by way of this domain with the E47 protein in vivo and
regulate the expression of enhancers.
Biochemistry: Voronova and Baltimore
4726 Biochemistry: Voronova and Baltimore
We thank Cornelis Murre, Mark Kamps, Richard Van Etten, and
Sankar Ghosh for helpful advice and discussion. We also thank
Robert Weinberg and Dan Silver for reading the manuscript. A.V. is
supported by a postdoctoral fellowship from The American Cancer
Society. This work was supported by U.S. Public Health Service
Grant GM 39458.
1. Murre, C., McCaw, P. S. & Baltimore, D. (1989) Cell 56,
777-783.
2. Murre, C., McCaw, P. S., Vaessin, H., Caudy, M., Jan, L. Y.,
Jan, Y. N., Cabrera, C., Buskin, D. C., Lassar, A. B., Wein-
traub, H. & Baltimore, D. (1989) Cell 58, 537-544.
3. Sen, R. & Baltimore, D. (1986) Cell 46, 705-716.
4. Lenardo, M., Pierce, J. W. & Baltimore, D. (1987) Science 236,
1573-1577.
5. Moss, L. G., Moss, J. B. & Rutter, W. J. (1988) Mol. Cell.
Biol. 8, 2620-2627.
6. Buskin, J. N. & Hauschka, S. D. (1989) Mol. Cell. Biol. 9,
2627-2640.
7. Davis, R. L., Weintraub, H. & Lassar, A. B. (1987) Cell 51,
987-1000.
8. Tapscott, S. J., Davis, R. L., Thayer, M. J., Cheng, P. F.,
Weintraub, H. & Lassar, A. B. (1988) Science 242, 405-411.
9. Wright, W. E., Sassoon, D. A. & Lin, V. K. (1989) Cell 56,
607-617.
10. Braun, T., Buschhausen-Denker, G., Bober, E., Tannich, E. &
Arnold, H. H. (1989) EMBO J. 8, 701-709.
11. Alonso, M. C. & Cabrera, C. V. (1988) EMBO J. 7, 2585-2591.
12. Villares, R. & Cabrera, C. V. (1987) Cell 36, 101-109.
13. Caudy, M., Vaessin, H., Brand, M., Tuma, R., Jan, L. Y. &
Jan, Y. N. (1988) Cell 55, 1061-1067.
14. Thisse, B., Stoetzel, C., Gorostiza-Thisse, C. & Perrin-
Schmitt, F. (1988) EMBO J. 7, 2175-2183.
15. Klaembt, C., Knust, E., Tietze, K. & Campos-Ortega, J. A.
(1989) EMBO J. 8, 203-211.
16. Mellentin, J. D., Smith, S. D. & Clearly, M. L. (1989) Cell 58,
77-83.
17. Gentz, R., Rauscher, F. J., III, Abate, C. & Curran, T. (1989)
Science 243, 1695-1699.
18. Turner, R. & Tjian, R. (1989) Science 243, 1689-1694.
19. Davis, R. L., Cheng, P.-F., Lassar, A. B. & Weintraub, H.
(1990) Cell 60, 733-746.
20. Vinson, C. R., Sigler, P. B. & McKnight, S. L. (1989) Science
246, 911-916.
21. Henthorn, P., Kiledjian, M. & Kadesch, T. (1990) Science 247,
467-470.
22. Benezra, R., Davis, R. L., Lockshon, D. L. & Weintraub, H.
(1990) Cell 61, 49-59.
Proc. NatL Acad. Sci. USA 87 (1990)
